Transfer Pricing for Intangibles in India: DEMPE & ITAT
CA Amit Bansal
CA Amit Bansal is a Fellow Chartered Accountant with over a decade of experience in accounting, auditing, and advisory. As Partner at GMCS & Co. and Founder of ABVS Management Consultancy, he leads key assurance and compliance projects across industries. He holds ICAI certifications in Forensic Accounting (FAFD), Concurrent Audit of Banks, ADR, and IND AS, and is a certified Peer Reviewer, known for his commitment to audit quality and integrity.
1. DEMPE – Moving Beyond Legal Ownership
- Who actually develops the intangible?
- Who bears enhancement risk?
- Who funds and supervises R&D?
- Who performs strategic decision-making?
- Who assumes failure risk?
Practical Shift Observed
- Whether Indian employees are engaged in core R&D functions
- Whether the Indian entity exercises control over strategic decisions
- Whether cost-plus compensation adequately reflects functional intensity
2. Development vs. Exploitation Risk – Where the Real Dispute Lies
Development Risk
- R&D failure
- Technology obsolescence
- Regulatory uncertainty
- Market viability
Exploitation Risk
- Market expansion
- Brand positioning
- Distribution strategy
- Commercial pricing
- Contract R&D models (low risk, routine compensation)
- Entrepreneurial R&D models (high risk, residual return entitlement)
3. Royalty Benchmarking – CUP vs. TNMM Debate
- Whether royalty should be benchmarked separately
- Whether the Transactional Net Margin Method (TNMM) at the entity level subsumes royalty
- Whether the Comparable Uncontrolled Price (CUP) is mandatory for royalty
ITAT’s Evolving Approach
- If royalty is closely linked to manufacturing or distribution activity, and TNMM at the entity level demonstrates arm’s length margin, separate benchmarking may not be required.
- However, where royalty is substantial and materially impacts profitability, separate benchmarking using CUP may be justified.
4. Intangible Valuation – Substance Over Formula
- Industry royalty ranges
- Nature of technology (unique vs. standard)
- Brand strength and geographic market
- Exclusivity rights
- Duration of license
- Whether the royalty is linked to sales, production, or profits
- Royalty for high-end pharmaceutical patents cannot be equated with trademark licensing in FMCG.
- Technology transfer in automotive manufacturing differs materially from software algorithm licensing.
5. Safe Harbour Provisions – Comfort with Limitations
- Threshold-based eligibility
- Prescribed margins or rates
- Mandatory compliance conditions
- No flexibility once opted.
6. Key ITAT Themes Emerging
1. Economic Substance Prevails
2. Risk Must Be Demonstrated, Not Claimed
3. Royalty Cannot Be Disallowed Merely for Being High
4. Aggregation vs. Segregation Depends on Facts
5. Revenue Authorities Cannot Impose Subjective Caps
7. Advisory Takeaways for Tax Professionals
- Conduct a detailed FAR analysis aligned with DEMPE.
- Document who controls strategic R&D decisions.
- Maintain board minutes and decision trails evidencing risk control.
- Prepare industry-specific royalty benchmarking studies.
- Avoid generic inter-company agreements.
- Evaluate APA vs. safe harbour vs. litigation strategy.
Conclusion: Intangibles Demand Intellectual Discipline
Disclaimer
The material presented on this blog is intended solely for informational purposes. The opinions expressed here are solely those of the respective authors and do not necessarily reflect the views of Fintrac Advisors. No warranties are made regarding the completeness, reliability, or accuracy of this information. Any actions taken based on the information presented in this blog are solely at the reader’s risk, and we will not be liable for any losses or damages resulting from its use. Seeking professional expertise for such matters is strongly recommended. External links on this blog may direct users to third-party sites beyond our control. We do not take responsibility for their nature, content, or availability.
For any clarifications or queries, please feel free to reach out to us at: admin@fintracadvisors.com
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

